Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KOVAI MEDICAL 2020-21 Annual Report Analysis
Wed, 31 Mar

KOVAI MEDICAL has announced its results for the year ended March 2021. Let us have a look at the detailed performance review of the company during FY20-21.

KOVAI MEDICAL Income Statement Analysis

  • Operating income during the year fell 3.0% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 14.2% YoY during the fiscal. Operating profit margins witnessed a fall and down at 28.3% in FY21 as against 24.0% in FY20.
  • Depreciation charges increased by 30.5% and finance costs increased by 89.8% YoY, respectively.
  • Other income grew by 11.9% YoY.
  • Net profit for the year declined by 17.9% YoY.
  • Net profit margins during the year declined from 13.3% in FY20 to 11.3% in FY21.

KOVAI MEDICAL Income Statement 2020-21

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Net Sales Rs m 7,117 6,904 -3.0%
Other income Rs m 106 119 11.9%
Total Revenues Rs m 7,223 7,022 -2.8%
Gross profit Rs m 1,711 1,954 14.2%
Depreciation Rs m 521 680 30.5%
Interest Rs m 176 335 89.8%
Profit before tax Rs m 1,119 1,057 -5.5%
Tax Rs m 173 281 61.9%
Profit after tax Rs m 946 777 -17.9%
Gross profit margin % 24.0 28.3
Effective tax rate % 15.5 26.5
Net profit margin % 13.3 11.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Download Now: Exclusive Guide About India's Potentially Decade-Long $10 Trillion Bull Run...

KOVAI MEDICAL Balance Sheet Analysis

  • The company's current liabilities during FY21 stood at Rs 1 billion as compared to Rs 1 billion in FY20, thereby witnessing an increase of 32.1%.
  • Long-term debt stood at Rs 6 billion as compared to Rs 5 billion during FY20, a growth of 9.1%.
  • Current assets rose 34% and stood at Rs 2 billion, while fixed assets rose 13% and stood at Rs 11 billion in FY21.
  • Overall, the total assets and liabilities for FY21 stood at Rs 13 billion as against Rs 11 billion during FY20, thereby witnessing a growth of 16%.

KOVAI MEDICAL Balance Sheet as on March 2021

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Networth Rs m 4,310 5,100 18.3
 
Current Liabilities Rs m 1,047 1,382 32.1
Long-term Debt Rs m 5,046 5,507 9.1
Total Liabilities Rs m 11,072 12,808 15.7
 
Current assets Rs m 1,403 1,883 34.2
Fixed Assets Rs m 9,669 10,925 13.0
Total Assets Rs m 11,072 12,808 15.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



KOVAI MEDICAL Cash Flow Statement Analysis

  • KOVAI MEDICAL's cash flow from operating activities (CFO) during FY21 stood at Rs 2 billion, an improvement of 22.7% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY21 stood at Rs -2 billion on a YoY basis.
  • Cash flow from financial activities (CFF) during FY21 stood at Rs 380 million on a YoY basis.
  • Overall, net cash flows for the company during FY21 stood at Rs -1 billion from the Rs -698 million net cash flows seen during FY20.

KOVAI MEDICAL Cash Flow Statement 2020-21

Particulars No. of months 12 12 % Change
Year Ending Mar-20 Mar-21
Cash Flow from Operating Activities Rs m 1,520 1,864 22.7%
Cash Flow from Investing Activities Rs m -2,557 -1,805 -
Cash Flow from Financing Activities Rs m 1,128 380 -66.3%
Net Cash Flow Rs m -698 -1,043 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for KOVAI MEDICAL

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 71.0, an decline from the EPS of Rs 86.5 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 1,102.7, stands at 15.5 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 2.4 times, while the price to sales ratio stands at 1.7 times.
  • The company's price to cash flow (P/CF) ratio stood at 6.8 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Sales per share (Unadj.) Rs 650.6 631.0
TTM Earnings per share Rs 86.5 71.0
Diluted earnings per share Rs 86.4 71.0
Price to Cash Flow x 5.1 6.8
TTM P/E ratio x 7.9 15.5
Price / Book Value ratio x 1.7 1.9
Market Cap Rs m 7,459 9,912
Dividends per share (Unadj.) Rs 3.0 3.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for KOVAI MEDICAL

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.4x during FY21, from 1.3x during FY20. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 4.2x during FY21, from 7.3x during FY20. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 15.2% during FY21, from 21.9% during FY21. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 13.1% during FY21, from 13.8% during FY20. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 8.7% during FY21, from 10.1% during FY20. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Current ratio x 1.3 1.4
Debtors’ Days Days 43 56
Interest coverage x 7.3 4.2
Debt to equity ratio x 1.2 1.1
Return on assets % 10.1 8.7
Return on equity % 21.9 15.2
Return on capital employed % 13.8 13.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how KOVAI MEDICAL has performed over the last 5 years, please visit here.

KOVAI MEDICAL Share Price Performance

Over the last one year, KOVAI MEDICAL share price has moved up from Rs 679.9 to Rs 1,102.7, registering a gain of Rs 422.8 or around 62.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,328.2 (up 0.4%). Over the last one year it has moved up from 12,148.6 to 21,328.2, a gain of 9,180 points (up 75.6%).

Overall, the S&P BSE SENSEX is up 74.1% over the year.

(To know more, check out historical annual results for KOVAI MEDICAL and quarterly results for KOVAI MEDICAL)

Annual Report FAQs

What is the current share price of KOVAI MEDICAL?

KOVAI MEDICAL currently trades at Rs 4,193.4 per share. You can check out the latest share price performance of KOVAI MEDICAL here...

What was the revenue of KOVAI MEDICAL in FY21? How does it compare to earlier years?

The revenues of KOVAI MEDICAL stood at Rs 7,022 m in FY21, which was down -2.8% compared to Rs 7,223 m reported in FY20.

KOVAI MEDICAL's revenue has grown from Rs 5,371 m in FY17 to Rs 7,022 m in FY21.

Over the past 5 years, the revenue of KOVAI MEDICAL has grown at a CAGR of 6.9%.

What was the net profit of KOVAI MEDICAL in FY21? How does it compare to earlier years?

The net profit of KOVAI MEDICAL stood at Rs 777 m in FY21, which was down -17.9% compared to Rs 946 m reported in FY20.

This compares to a net profit of Rs 601 m in FY19 and a net profit of Rs 580 m in FY18.

Over the past 5 years, KOVAI MEDICAL net profit has grown at a CAGR of 6.6%.

What does the cash flow statement of KOVAI MEDICAL reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of KOVAI MEDICAL reveals:

  • Cash flow from operations increased in FY21 and stood at Rs 1,864 m as compared to Rs 1,520 m in FY20.
  • Cash flow from investments increased in FY21 and stood at Rs -1,805 m as compared to Rs -2,557 m in FY20.
  • Cash flow from financial activity decreased in FY21 and stood at Rs 380 m as compared to Rs 1,128 m in FY20.

Here's the cash flow statement of KOVAI MEDICAL for the past 5 years.

(Rs m)FY17FY18FY19FY20FY21
From Operations9918691,2611,5201,864
From Investments-320-1,227-2,766-2,557-1,805
From Financial Activity-4975981,6011,128380
Net Cashflow-335-447-657-698-1,043

What does the Key Ratio analysis of KOVAI MEDICAL reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of KOVAI MEDICAL reveals:

  • Operating profit margins witnessed a fall and down at 28.3% in FY21 as against 24.0% in FY20.
  • Net profit margins declined from 13.3% in FY20 to 11.3% in FY21.
  • Debt to Equity ratio for FY21 stood at 1.1 as compared to 1.2 in FY20.

Here's the ratio/financial analysis of KOVAI MEDICAL for the past 5 years.

 FY17FY18FY19FY20FY21
Operating Profit Margin (%)23.521.821.524.028.3
Net Profit Margin (%)11.39.89.613.311.3
Debt to Equity Ratio (x)0.40.61.01.21.1

Read: Latest Annual Report Analysis of KOVAI MEDICAL

Equitymaster requests your view! Post a comment on "KOVAI MEDICAL 2020-21 Annual Report Analysis". Click here!